Establishes "Colton's Law" relating to certain pediatric disorders

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor: Brattin, Rick; House handler: N/A
Last action: 2026-03-31
Official status: Hearing Conducted S Insurance and Banking Committee
Effective date: 2026-08-28

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

2026-03-31 Missouri House of Representatives and Missouri Senate
Hearing Conducted S Insurance and Banking Committee
2026-01-27 S240
Second Read and Referred S Insurance and Banking Committee
2026-01-07 S75
S First Read
2025-12-01 Missouri House of Representatives and Missouri Senate
Prefiled

Official Summary Text

The following summaries of this bill are available:

Print All Summaries

Introduced

Print

SB 1263 - This act establishes "Colton's Law." Under this act, MO HealthNet and private health insurance carriers and health benefit plans for plans delivered, issued for delivery, continued, or renewed on or after January 1, 2027, shall provide coverage for medically necessary physician-prescribed treatment for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS). Coverage shall include antibiotics, medications, behavioral therapies, immunomodulating medicines, plasma exchange, and intravenous immunoglobulin therapy, to the extent described in the act and subject to no greater copayments, coinsurance, or deductibles than similar benefits provided by the health carrier or benefit plan.
SARAH HASKINS